HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities research analysts at HC Wainwright lifted their Q2 2025 earnings estimates for HIVE Blockchain Technologies in a research note issued on Thursday, August 15th. HC Wainwright analyst M. Colonnese now forecasts that the company will earn ($0.11) per share for the quarter, up from their previous forecast of ($0.23). HC Wainwright currently has a “Strong-Buy” rating on the stock. HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q3 2025 earnings at ($0.10) EPS and Q4 2025 earnings at ($0.06) EPS.
HIVE Blockchain Technologies (CVE:HIV – Get Free Report) last issued its quarterly earnings data on Monday, June 24th. The company reported C($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of C($0.18) by C$0.14. The company had revenue of C$49.72 million for the quarter, compared to analyst estimates of C$53.64 million.
HIVE Blockchain Technologies Price Performance
Recommended Stories
- Five stocks we like better than HIVE Blockchain Technologies
- Why Are Stock Sectors Important to Successful Investing?
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- 3 Healthcare Dividend Stocks to Buy
- 2 Option Strategies to Maximize Profits in a Bear Market
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
